查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
睡眠呼吸中止症設備的全球市場規模、佔有率和趨勢：按產品類型、診斷設備、年齡層、性別、最終用戶、地區 - 預測（截至 2029 年）
市場調查報告書
商品編碼
1520995

睡眠呼吸中止症設備的全球市場規模、佔有率和趨勢：按產品類型、診斷設備、年齡層、性別、最終用戶、地區 - 預測（截至 2029 年）

Sleep Apnea Devices Market Size, Share & Trends by products (Therapeutic (PAP ), Facial Interfaces, Oral Appliances, Accessories), Diagnostic Devices, Age Group, Gender type, End User & Region - Global Forecasts to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 367 Pages | 訂單完成後即時交付

價格

預計 2024 年全球睡眠呼吸中止設備市場規模將達 65 億美元，預計到 2029 年將達到 93 億美元，預測期內複合年成長率為 7.3%。

睡眠呼吸中止症設備被睡眠實驗室、診所、醫院和家庭用戶廣泛使用。隨著患者更喜歡非侵入性治療方法， CPAP 和 BPAP 機等設備的使用正在增加。亞太地區等新興市場為市場提供了利潤豐厚的成長機會。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
單元 10億美元
部分 按產品、最終用戶、年齡層、性別
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲、海灣合作理事會國家

“從產品來看，治療設備領域將在預測期內佔據市場最高成長率。”

此細分市場的主要成長動力包括家庭睡眠測試支援的診斷產量的提高，從而導致對治療設備的需求。

“就最終用戶而言，居家照護環境/個人細分市場將在預測期內佔據市場最高成長率。”

人們對居家醫療解決方案的日益青睞正在推動家庭睡眠呼吸中止症設備的採用。居家睡眠呼吸中止症測試的良好可近性正在改善睡眠呼吸中止症的診斷和後續治療，影響市場成長。

本報告研究分析了全球睡眠呼吸中止症設備市場，提供了關鍵促進因素和限制因素、競爭格局和未來趨勢等資訊。

目錄

第1章 簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

  • 睡眠呼吸中止症設備市場概述
  • 睡眠呼吸中止症設備市場：依產品分類（2024-2029）
  • 北美睡眠呼吸中止設備市場：按產品、按國家/地區分類（2023 年）
  • 地理成長機會（2024-2029）

第5章市場概況

  • 介紹
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 任務
  • 價格分析
    • 睡眠呼吸中止症產品的平均售價：按地區
    • 平均售價範圍：依產品類型
  • 價值鏈分析
  • 供應鏈分析
  • 波特五力分析
  • 主要相關利益者和採購標準
  • 生態系分析
  • 監管分析
    • 監管環境
    • 監管機構、政府機構和其他組織名單
  • 專利分析
  • 影響客戶業務的趨勢/干擾
  • 重大會議和活動（2024-2025）
  • 技術分析
    • 主要技術
    • 鄰近技術
  • 貿易分析
    • HS 編碼 901920 的進口資料
    • HS 編碼 901920 的出口資料
  • 投資金籌措場景
  • 生成式人工智慧對睡眠呼吸中止症設備市場的影響

第6章 睡眠呼吸中止症的流行病學評估

  • 介紹
  • 流行病學評估
  • 處方模式評估
  • 依從性評估

第 7 章睡眠呼吸中止症的替代治療

  • 介紹
  • EPAP
  • 舌下神經刺激
  • 口腔壓力療法
  • 體位療法

第8章睡眠呼吸中止設備市場：依產品

  • 介紹
  • 治療設備
    • 氣道通氣設備
    • 持續性氣道正壓通氣設備
    • APAP設備
    • BPAP設備
    • 臉部介面
    • 配件
    • 口內矯正器
    • 其他處理設備
  • 診斷設備
    • PSG設備
    • 居家睡眠測試設備
    • 血氧計
    • 腕動計系統
    • 睡眠篩檢設備

第9章睡眠呼吸中止設備市場：依最終用戶分類

  • 介紹
  • 睡眠實驗室、診所、醫院
  • 居家照護環境/個人

第10章睡眠呼吸中止設備市場：依年齡層

  • 介紹
  • 40歲以下
  • 40-60歲
  • 60歲以上

第11章睡眠呼吸中止設備市場：性別

  • 介紹
  • 男性患者
  • 女病人

第12章睡眠呼吸中止設備市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 澳洲
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中東/非洲
  • 海灣合作理事會國家
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
  • 其他海灣合作理事會國家

第13章競爭格局

  • 介紹
  • 主要企業策略/主要企業
  • 收益分析
  • 市場佔有率分析
  • 企業評價矩陣：主要企業（2023年）
  • 企業評估矩陣：Start-Ups/中小企業（2023）
  • 公司評價及財務指標
  • 品牌/產品比較
  • 競爭場景

第14章 公司簡介

  • 主要企業
    • RESMED
    • KONINKLIJKE PHILIPS NV
    • FISHER & PAYKEL HEALTHCARE LIMITED
    • INSPIRE MEDICAL SYSTEMS, INC.
    • SOMNOMED
    • OPENAIRWAY
    • COMPUMEDICS LIMITED
    • LOWENSTEIN MEDICAL TECHNOLOGY GMBH+CO. KG
    • DRIVE DEVILBISS HEALTHCARE
    • BMC MEDICAL CO., LTD.
    • BRAEBON MEDICAL CORPORATION
    • DYNAFLEX
    • PANTHERA DENTAL
    • MYERSON LLC
    • PROSOMNUS SLEEP TECHNOLOGIES
  • 其他公司
    • NIDEK MEDICAL INDIA
    • TOMED GMBH
    • LIVANOVA PLC
    • INVACARE CORPORATION
    • MPOWRX HEALTH & WELLNESS PRODUCTS INC.
    • NIHON KOHDEN CORPORATION
    • SICAT GMBH & CO. KG
    • VIVOS THERAPEUTICS, INC.
    • AIRWAY MANAGEMENT
    • APNEA SCIENCES

第15章附錄

Product Code: MD 1181

The sleep apnea devices market is valued at an estimated USD 6.5 billion in 2024 and is projected to reach USD 9.3 billion by 2029 at a CAGR of 7.3% during the forecast period. Sleep apnea devices is widely used by sleep laboratories, clinics, hospitals and home users. Patients prefer non-invasive treatment methods, leading to increased use of devices like CPAP and BPAP machines. Emeriging markets such as Asia Pacific region offer lucrative growth opportunities for sleep apnea devices market.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsBy Product, end user, age group and gender
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries

"Therapeutic devices segment accounted for the highest growth rate in the sleep apnea devices market, by product, during the forecast period."

The sleep apnea devices market is bifurcated into therapeutic devices and diagnostic devices. Sleep apnea therapeutic devices covers positive airway pressure (PAP) devices, facial interfaces (masks), accessories, oral appliances, and other therapeutic devices. Major factors driving the growth of this segment include improving diagnosis rate backed by home sleep tests leading to demand for therapeutic devices.

"Home care settings/individuals segment accounted for the highest growth rate in the sleep apnea devices market, by end users, during the forecast period."

The sleep apnea devices market is bifurcated into into sleep laboratories, clinics, and hospitals and home care settings/individuals. The growing preference for home healthcare solutions is driving the adoption of home-use sleep apnea devices. Better accessibility of home sleep apnea tests is key reason for greater diagnosis and subsequent treatment of sleep apnea impacting market growth.

"Asia Pacific: The fastest-growing region sleep apnea devices market."

The worldwide market for human identification is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region market is expected to register the highest growth rate during the forecast period, mainly due to the frequent product launches and regulatory approvals of new devices leading to market offerings in the region.

The break-up of the profile of primary participants in the sleep apnea devices market:

  • By Company Type: Tier 1 - 55%, Tier 2 - 40%, and Tier 3 - 5%
  • By Designation: C-level - 37%, D-level - 48%, and Others - 15%
  • By Region: North America - 56%, Europe - 20%, Asia Pacific - 17%, Rest of the World - 7%

The key players in this market are ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare Limited (New Zealand), Inspire Medical Systems, Inc. (US), SomnoMed (Australia), Openairway (Canada), Compumedics Limited (Australia), Lowenstein Medical Technology GmbH + Co. K.G. (Germany), Drive DeVilbiss Healthcare (US), BMC Medical Co., Ltd. (China), BRAEBON Medical Corporation (Canada), DynaFlex (US), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Tomed GmbH (Germany), LivaNova PLC (UK), Invacare Corporation (US), MPowrx Health & Wellness Products Inc. (Canada), Nihon Kohden Corporation (Japan), SICAT GmbH & Co. Kg (Germany), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US).

Research Coverage:

This research report categorizes the sleep apnea devices market by product (Therapeutic devices (PAP devices, facial interfaces, accessories, oral appliances, other therapeutic devices), Diagnostic devices (PSG Devices, home sleep testing devices, oximeters, actigraphy systems, sleep screening devices)), by end user (Sleep laboratories, clinics, and hospitals, and home care settings/ individuals), by age group (below 40 years, 40-60 years, and above 60 years), by gender (male patients, female patients), and by region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the sleep apnea devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches and recent developments associated with the sleep apnea devices market. Competitive analysis of upcoming startups in the sleep apnea devices market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall sleep apnea devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (large pool of undiagnosed sleep apnea patients, favorable reimbursement and financial aid for sleep apnea devices and therapies, growing awareness about effects of untreated sleep apnea among patients, increasing usage of oral appliances among patients with mild to low-moderate sleep apnea, increased investments and funding to develop advanced sleep apnea products), restraints (high cost of CPAP machines and minimal insurance access in emerging economies, complex referral pathways, long waiting periods, amd delayed diagnosis, and use of alternative therapies and medications for sleep apnea), opportunities (rising demand for sleep apnea tests as cost saving measures, imcreasing focus on telemedicine, mHealth, and artificial intelligence, growing focus of key sleep apnea device manufacturers toward emerging markets) and challenges (Poor patient compliance with CPAP therapy) influencing the growth of the sleep apnea devices market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the sleep apnea devices market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the sleep apnea devices market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the sleep apnea devices market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare Limited (New Zealand).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 SEGMENTS COVERED
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of key secondary sources
      • 2.1.1.2 Key data from secondary sources
      • 2.1.1.3 Objectives of secondary research
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 List of key primaries
      • 2.1.2.2 Objectives of primary research
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Key data from primary sources
      • 2.1.2.5 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Company revenue estimation approach
      • 2.2.1.2 Company presentations and primary interviews
      • 2.2.1.3 Patient-based approach (sleep apnea oral appliances)
      • 2.2.1.4 Patient-based approach (PAP devices)
      • 2.2.1.5 Growth forecast
      • 2.2.1.6 CAGR projections
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 SLEEP APNEA DEVICES MARKET OVERVIEW
  • 4.2 SLEEP APNEA DEVICES MARKET, BY PRODUCT (2024-2029)
  • 4.3 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT AND COUNTRY (2023)
  • 4.4 GEOGRAPHIC GROWTH OPPORTUNITIES (2024-2029)

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Large pool of undiagnosed sleep apnea patients
      • 5.2.1.2 Favorable reimbursement and financial aid for sleep apnea devices and therapies
      • 5.2.1.3 Growing awareness about effects of untreated sleep apnea among patients
      • 5.2.1.4 Increasing usage of oral appliances among patients with mild-to-moderate sleep apnea
      • 5.2.1.5 Increased investments and funding to develop advanced sleep apnea products
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of CPAP machines and minimal insurance access in emerging economies
      • 5.2.2.2 Complex referral pathways, long waiting periods, and delayed diagnosis
      • 5.2.2.3 Use of alternative therapies and medications for sleep apnea
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising demand for cost-effective home sleep apnea tests
      • 5.2.3.2 Increasing focus on telemedicine, mHealth, and artificial intelligence
      • 5.2.3.3 Growing focus of key sleep apnea device manufacturers toward emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Poor patient compliance with CPAP therapy
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE OF SLEEP APNEA PRODUCTS, BY REGION
    • 5.3.2 AVERAGE SELLING PRICE RANGE, BY PRODUCT TYPE
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 THREAT OF SUBSTITUTES
    • 5.6.3 BARGAINING POWER OF SUPPLIERS
    • 5.6.4 BARGAINING POWER OF BUYERS
    • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.7 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.7.2 KEY BUYING CRITERIA
  • 5.8 ECOSYSTEM ANALYSIS
    • 5.8.1 ROLE IN ECOSYSTEM
  • 5.9 REGULATORY ANALYSIS
    • 5.9.1 REGULATORY LANDSCAPE
      • 5.9.1.1 North America
        • 5.9.1.1.1 US
          • 5.9.1.1.1.1 Reimbursement scenario in US
        • 5.9.1.1.2 Canada
      • 5.9.1.2 Europe
      • 5.9.1.3 Asia Pacific
        • 5.9.1.3.1 Japan
        • 5.9.1.3.2 China
        • 5.9.1.3.3 India
        • 5.9.1.3.4 Australia
    • 5.9.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 5.9.2.1 List of key regulatory bodies, government agencies, and other organizations
        • 5.9.2.1.1 North America
        • 5.9.2.1.2 Europe
        • 5.9.2.1.3 Asia Pacific
        • 5.9.2.1.4 Latin America
        • 5.9.2.1.5 Middle East & Africa
      • 5.9.2.2 List of other regulatory bodies, government agencies, and other organizations
  • 5.1 PATENT ANALYSIS
  • 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.11.1 REVENUE SHIFT AND POCKETS FOR SLEEP APNEA ORAL APPLIANCE MANUFACTURERS
  • 5.12 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.13 TECHNOLOGY ANALYSIS
    • 5.13.1 KEY TECHNOLOGIES
      • 5.13.1.1 PAP devices
    • 5.13.2 ADJACENT TECHNOLOGIES
      • 5.13.2.1 Oral appliances
  • 5.14 TRADE ANALYSIS
    • 5.14.1 IMPORT DATA FOR HS CODE 901920
    • 5.14.2 EXPORT DATA FOR HS CODE 901920
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 IMPACT OF GENERATIVE AI ON SLEEP APNEA DEVICES MARKET

6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA

  • 6.1 INTRODUCTION
  • 6.2 EPIDEMIOLOGICAL ASSESSMENT
  • 6.3 PRESCRIPTION PATTERN ASSESSMENT
  • 6.4 ADHERENCE ASSESSMENT

7 ALTERNATE THERAPIES FOR SLEEP APNEA

  • 7.1 INTRODUCTION
  • 7.2 EXPIRATORY PAP
  • 7.3 HYPOGLOSSAL NERVE STIMULATION
  • 7.4 ORAL PRESSURE THERAPY
  • 7.5 POSITIONAL THERAPY

8 SLEEP APNEA DEVICES MARKET, BY PRODUCT

  • 8.1 INTRODUCTION
  • 8.2 THERAPEUTIC DEVICES
    • 8.2.1 PAP DEVICES
    • 8.2.2 CPAP DEVICES
      • 8.2.2.1 Technological advancements and better reimbursement facilities to boost segment growth
    • 8.2.3 APAP DEVICES
      • 8.2.3.1 Increasing patient non-compliance with CPAP devices to augment segment growth
    • 8.2.4 BPAP DEVICES
      • 8.2.4.1 Increased product recalls and more complex operations to lower adoption
    • 8.2.5 FACIAL INTERFACES
      • 8.2.5.1 Masks
        • 8.2.5.1.1 Full-face masks
          • 8.2.5.1.1.1 Full-face masks to be most effective for mouth breathers or patients struggling with breathing through nose
        • 8.2.5.1.2 Nasal pillow masks
          • 8.2.5.1.2.1 Greater patient compliance and high preference for masks without headgear or straps to support segment
        • 8.2.5.1.3 Nasal masks
          • 8.2.5.1.3.1 Ease of use and less claustrophobic nature to aid adoption
      • 8.2.5.2 Cushions
        • 8.2.5.2.1 Favorable insurance coverage to propel segment growth
    • 8.2.6 ACCESSORIES
      • 8.2.6.1 Humidifier accessories
        • 8.2.6.1.1 Humidifiers to open airways, decrease congestion, and encourage clearer breathing
      • 8.2.6.2 Power accessories
        • 8.2.6.2.1 Power accessories to manage uninterrupted sleep apnea therapy in absence of power supply
      • 8.2.6.3 Transportation accessories
        • 8.2.6.3.1 Need to carry sleep apnea devices while traveling to spur segment growth
      • 8.2.6.4 Communication accessories
        • 8.2.6.4.1 Increasing need for easy teleconsultations for remote patients to fuel segment growth
      • 8.2.6.5 Chain restraints
        • 8.2.6.5.1 Growing need for obstructive sleep apnea management with therapeutic devices to drive segment
      • 8.2.6.6 Other accessories
    • 8.2.7 ORAL APPLIANCES
      • 8.2.7.1 Mandibular advancement devices
        • 8.2.7.1.1 Low cost and better research on device advantages to propel market growth
      • 8.2.7.2 Tongue-retaining devices
        • 8.2.7.2.1 Need for more affordable and comfortable treatment options to support segment growth
      • 8.2.7.3 Daytime-Nighttime appliances
        • 8.2.7.3.1 Increased focus on comfortable, non-surgical, and low-risk treatments to drive segment
    • 8.2.8 OTHER THERAPEUTIC DEVICES
  • 8.3 DIAGNOSTIC DEVICES
    • 8.3.1 PSG DEVICES
      • 8.3.1.1 Ambulatory PSG devices
        • 8.3.1.1.1 High need for cost-effective and technologically advanced devices to propel segment growth
      • 8.3.1.2 Clinical PSG devices
        • 8.3.1.2.1 Labor-intensive and expensive procedures to limit segment
    • 8.3.2 HOME SLEEP TESTING DEVICES
      • 8.3.2.1 Increased need for cost-effective and comfortable home sleep testing devices to augment segment growth
    • 8.3.3 OXIMETERS
      • 8.3.3.1 Fingertip oximeters
        • 8.3.3.1.1 Lack of precise reading due to injury or slow blood flow to limit segment
      • 8.3.3.2 Handheld oximeters
        • 8.3.3.2.1 Easy customizations and ease of distant reading to spur segment growth
      • 8.3.3.3 Wrist-worn oximeters
        • 8.3.3.3.1 Small size and easy portability for overnight monitoring to propel segment growth
      • 8.3.3.4 Tabletop oximeters
        • 8.3.3.4.1 Higher cost and fewer applications for personal use to decrease market share
    • 8.3.4 ACTIGRAPHY SYSTEMS
      • 8.3.4.1 Increased research on sleep and wake patterns to drive market
    • 8.3.5 SLEEP SCREENING DEVICES
      • 8.3.5.1 Increasing preference for home-based sleep apnea testing to propel market growth

9 SLEEP APNEA DEVICES MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 SLEEP LABORATORIES, CLINICS, AND HOSPITALS
    • 9.2.1 INCREASING NEED FOR ADVANCED DIAGNOSTIC DEVICES AND HIGHLY PRECISE DIAGNOSIS TO SUPPORT MARKET GROWTH
  • 9.3 HOME CARE SETTINGS/INDIVIDUALS
    • 9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET GROWTH

10 SLEEP APNEA DEVICES MARKET, BY AGE GROUP

  • 10.1 INTRODUCTION
  • 10.2 BELOW 40 YEARS
    • 10.2.1 LOWER PREVALENCE OF SLEEP APNEA IN YOUNGER AGE GROUPS TO LIMIT MARKET GROWTH
  • 10.3 40-60 YEARS
    • 10.3.1 UNDERDIAGNOSIS AND UNHEALTHY LIFESTYLE TO AID MARKET GROWTH
  • 10.4 ABOVE 60 YEARS
    • 10.4.1 HIGH OCCURRENCE OF CHRONIC MEDICAL CONDITIONS AND SLEEP-RELATED DISORDERS TO DRIVE MARKET

11 SLEEP APNEA DEVICES MARKET, BY GENDER

  • 11.1 INTRODUCTION
  • 11.2 MALE PATIENTS
    • 11.2.1 HIGHER PREVALENCE OF SLEEP-RELATED BREATHING DISORDERS TO BOOST MARKET GROWTH
  • 11.3 FEMALE PATIENTS
    • 11.3.1 UNDERDIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA TO LIMIT MARKET

12 SLEEP APNEA DEVICES MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 US
      • 12.2.1.1 US to dominate North American sleep apnea devices market during forecast period
    • 12.2.2 CANADA
      • 12.2.2.1 Increasing number of research grants and health programs to propel market growth
  • 12.3 EUROPE
    • 12.3.1 GERMANY
      • 12.3.1.1 High prevalence of obstructive sleep apnea and increased geriatric population to fuel market
    • 12.3.2 UK
      • 12.3.2.1 Rising awareness among patients about sleep apnea to support market growth
    • 12.3.3 FRANCE
      • 12.3.3.1 Rising geriatric population and obesity rates to fuel market growth
    • 12.3.4 ITALY
      • 12.3.4.1 Favorable initiatives by dental associations and increased awareness about obstructive sleep apnea to drive market
    • 12.3.5 SPAIN
      • 12.3.5.1 Social awareness initiatives by regional organizations to aid market growth
    • 12.3.6 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 CHINA
      • 12.4.1.1 Growing obesity and diabetes in adults to propel market growth
    • 12.4.2 JAPAN
      • 12.4.2.1 Favorable reimbursement scenario and high demand for cloud-connected sleep apnea therapeutic devices to aid market growth
    • 12.4.3 AUSTRALIA
      • 12.4.3.1 Increased number of sleep clinics to augment market growth
    • 12.4.4 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 BRAZIL
      • 12.5.1.1 Favorable reimbursement policies and increased awareness about sleeping disorders to drive market
    • 12.5.2 MEXICO
      • 12.5.2.1 Poor healthcare infrastructure and lack of public health initiatives to limit market growth
    • 12.5.3 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 PRESENCE OF KEY INTERNATIONAL PLAYERS AND HIGH INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET
  • 12.7 GCC COUNTRIES
    • 12.7.1 SAUDI ARABIA
      • 12.7.1.1 High obesity rates among women to propel market growth
    • 12.7.2 UAE
      • 12.7.2.1 Improved access to diagnostics to drive adoption of sleep apnea devices
  • 12.8 REST OF GCC COUNTRIES

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
    • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SLEEP APNEA DEVICES MARKET
  • 13.3 REVENUE ANALYSIS
  • 13.4 MARKET SHARE ANALYSIS
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Product footprint
      • 13.5.5.3 Region footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 13.7 COMPANY VALUATION & FINANCIAL METRICS
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 PRODUCT LAUNCHES & APPROVALS
    • 13.9.2 DEALS
    • 13.9.3 EXPANSIONS
    • 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 RESMED
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Product launches
        • 14.1.1.3.2 Deals
        • 14.1.1.3.3 Expansions
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Key strengths
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses & competitive threats
    • 14.1.2 KONINKLIJKE PHILIPS N.V.
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products offered
      • 14.1.2.3 MnM view
        • 14.1.2.3.1 Key strengths
        • 14.1.2.3.2 Strategic choices
        • 14.1.2.3.3 Weaknesses & competitive threats
    • 14.1.3 FISHER & PAYKEL HEALTHCARE LIMITED
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product launches
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Key strengths
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses & competitive threats
    • 14.1.4 INSPIRE MEDICAL SYSTEMS, INC.
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products offered
    • 14.1.5 SOMNOMED
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products offered
    • 14.1.6 OPENAIRWAY
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products offered
    • 14.1.7 COMPUMEDICS LIMITED
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Product approvals
    • 14.1.8 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products offered
    • 14.1.9 DRIVE DEVILBISS HEALTHCARE
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products offered
    • 14.1.10 BMC MEDICAL CO., LTD.
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products offered
    • 14.1.11 BRAEBON MEDICAL CORPORATION
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products offered
    • 14.1.12 DYNAFLEX
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products offered
      • 14.1.12.3 Recent developments
        • 14.1.12.3.1 Deals
    • 14.1.13 PANTHERA DENTAL
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products offered
      • 14.1.13.3 Recent developments
        • 14.1.13.3.1 Deals
        • 14.1.13.3.2 Other developments
    • 14.1.14 MYERSON LLC
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products offered
    • 14.1.15 PROSOMNUS SLEEP TECHNOLOGIES
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products offered
      • 14.1.15.3 Recent developments
        • 14.1.15.3.1 Deals
  • 14.2 OTHER PLAYERS
    • 14.2.1 NIDEK MEDICAL INDIA
    • 14.2.2 TOMED GMBH
    • 14.2.3 LIVANOVA PLC
      • 14.2.3.1 Recent developments
        • 14.2.3.1.1 Product approvals
    • 14.2.4 INVACARE CORPORATION
    • 14.2.5 MPOWRX HEALTH & WELLNESS PRODUCTS INC.
    • 14.2.6 NIHON KOHDEN CORPORATION
    • 14.2.7 SICAT GMBH & CO. KG
    • 14.2.8 VIVOS THERAPEUTICS, INC.
      • 14.2.8.1 Recent developments
        • 14.2.8.1.1 Product approvals
        • 14.2.8.1.2 Deals
        • 14.2.8.1.3 Expansions
    • 14.2.9 AIRWAY MANAGEMENT
      • 14.2.9.1 Recent developments
        • 14.2.9.1.1 Product launches
    • 14.2.10 APNEA SCIENCES

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 SLEEP APNEA DEVICES MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 SLEEP APNEA DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
  • TABLE 3 SLEEP APNEA DEVICES MARKET: RISK ASSESSMENT
  • TABLE 4 ESTIMATED PREVALENCE OF SLEEP APNEA, 2022-2024 (MILLION)
  • TABLE 5 REIMBURSEMENT CODES AND COSTS OF KEY SLEEP APNEA DEVICES BY RESMED
  • TABLE 6 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL LTD.
  • TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT EFFECTS OF UNTREATED SLEEP APNEA
  • TABLE 8 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR TREATING SLEEP APNEA
  • TABLE 9 AVERAGE SELLING PRICE OF SLEEP APNEA PRODUCTS, BY REGION
  • TABLE 10 AVERAGE SELLING PRICE RANGE, BY PRODUCT TYPE, 2021-2023
  • TABLE 11 SLEEP APNEA DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES (%)
  • TABLE 13 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES
  • TABLE 14 SLEEP APNEA DEVICES MARKET: ROLE IN ECOSYSTEM
  • TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
  • TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 19 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 LIST OF OTHER REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2024-DECEMBER 2025
  • TABLE 26 IMPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019-2023 (USD MILLION)
  • TABLE 27 EXPORT DATA FOR HS CODE 901920, BY COUNTRY, 2019-2023 (USD MILLION)
  • TABLE 28 SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 29 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 30 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 31 PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 32 PAP DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 33 CPAP DEVICES OFFERED BY KEY PLAYERS
  • TABLE 34 CPAP DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 35 APAP DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 BPAP DEVICES OFFERED BY KEY PLAYERS
  • TABLE 37 BPAP DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 39 FACIAL INTERFACES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 MASKS OFFERED BY KEY PLAYERS
  • TABLE 41 MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 42 MASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 43 FULL-FACE MASKS OFFERED BY KEY PLAYERS
  • TABLE 44 FULL-FACE MASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 45 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS
  • TABLE 46 NASAL PILLOW MASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 47 NASAL MASKS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 48 CUSHIONS OFFERED BY KEY PLAYERS
  • TABLE 49 CUSHIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 50 ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 51 ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 52 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 53 POWER ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 54 TRANSPORTATION ACCESSORIES MARKET, BY REGION,2022-2029 (USD MILLION)
  • TABLE 55 COMMUNICATION ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 CHIN RESTRAINTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 57 OTHER ACCESSORIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 ORAL APPLIANCES OFFERED BY KEY PLAYERS
  • TABLE 59 ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 60 ORAL APPLIANCES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 61 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 63 DAYTIME-NIGHTTIME APPLIANCES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 64 OTHER THERAPEUTIC DEVICES OFFERED BY KEY PLAYERS
  • TABLE 65 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 66 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 67 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 68 PSG DEVICES OFFERED BY KEY PLAYERS
  • TABLE 69 PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 PSG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 71 AMBULATORY PSG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 72 CLINICAL PSG DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 73 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 74 OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 76 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS
  • TABLE 77 FINGERTIP OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 78 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS
  • TABLE 79 HANDHELD OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 80 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS
  • TABLE 81 WRIST-WORN OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 82 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS
  • TABLE 83 TABLETOP OXIMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 84 LIST OF JOURNALS THAT ASSESS ROLE OF ACTIGRAPHY SYSTEMS IN SLEEP APNEA
  • TABLE 85 ACTIGRAPHY SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 86 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS
  • TABLE 87 SLEEP SCREENING DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 88 SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 89 SLEEP APNEA DEVICES MARKET FOR SLEEP LABORATORIES, CLINICS, AND HOSPITALS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 90 SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS,BY REGION, 2022-2029 (USD MILLION)
  • TABLE 91 SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 92 SLEEP APNEA DEVICES MARKET FOR BELOW 40 YEARS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 93 SLEEP APNEA DEVICES MARKET FOR 40-60 YEARS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 94 SLEEP APNEA DEVICES MARKET FOR ABOVE 60 YEARS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 95 SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 96 SLEEP APNEA DEVICES MARKET FOR MALE PATIENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 97 SLEEP APNEA DEVICES MARKET FOR FEMALE PATIENTS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 98 SLEEP APNEA DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 99 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 101 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 102 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 103 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 NORTH AMERICA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 NORTH AMERICA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 109 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 110 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 111 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 113 US: SLEEP APNEA PRODUCTS OFFERED BY KEY PLAYERS
  • TABLE 114 US: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 115 US: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 US: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (THOUSAND UNITS)
  • TABLE 117 US: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 118 US: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 US: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 US: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 121 US: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 122 US: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 US: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 US: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 US: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 126 US: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 127 US: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 128 CANADA: SLEEP APNEA PRODUCTS OFFERED BY KEY PLAYERS
  • TABLE 129 CANADA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 130 CANADA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 CANADA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 132 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 CANADA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 CANADA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 CANADA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 137 CANADA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 CANADA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 CANADA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 140 CANADA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 141 CANADA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 142 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 EUROPE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 144 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 145 EUROPE: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 EUROPE: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 EUROPE: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 149 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 150 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 EUROPE: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 EUROPE: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 154 EUROPE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 155 EUROPE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 156 GERMANY: SLEEP APNEA PRODUCTS PROVIDED BY MAJOR PLAYERS
  • TABLE 157 GERMANY: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 158 GERMANY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 GERMANY: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 161 GERMANY: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 GERMANY: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 GERMANY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 GERMANY: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 166 GERMANY: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 GERMANY: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 168 GERMANY: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 169 GERMANY: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 170 UK: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 171 UK: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 UK: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 UK: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 174 UK: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 UK: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 176 UK: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 UK: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 UK: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 UK: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 UK: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 181 UK: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 182 UK: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 183 FRANCE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 184 FRANCE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 185 FRANCE: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 187 FRANCE: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 FRANCE: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 189 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 190 FRANCE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 FRANCE: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 192 FRANCE: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 FRANCE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 194 FRANCE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 195 FRANCE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 196 ITALY: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 197 ITALY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 ITALY: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 ITALY: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 ITALY: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 202 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 ITALY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 ITALY: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 ITALY: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 ITALY: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 207 ITALY: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 208 ITALY: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 209 SPAIN: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 210 SPAIN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 SPAIN: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 SPAIN: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 214 SPAIN: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 215 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 216 SPAIN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 217 SPAIN: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 218 SPAIN: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 219 SPAIN: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 220 SPAIN: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 221 SPAIN: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 222 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 223 REST OF EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 224 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 REST OF EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 REST OF EUROPE: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 227 REST OF EUROPE: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 228 REST OF EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 229 REST OF EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 230 REST OF EUROPE: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 REST OF EUROPE: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 233 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 234 REST OF EUROPE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 235 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 237 ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 238 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 239 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 243 ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 245 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 249 CHINA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 250 CHINA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 251 CHINA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 252 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 253 CHINA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 254 CHINA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 255 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 CHINA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 CHINA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 CHINA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 259 CHINA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 260 CHINA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 261 CHINA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 262 JAPAN: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 263 JAPAN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 JAPAN: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 265 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 266 JAPAN: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 267 JAPAN: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 268 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 269 JAPAN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 JAPAN: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 271 JAPAN: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 JAPAN: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 273 JAPAN: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 274 JAPAN: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 275 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 276 AUSTRALIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 277 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 278 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 279 AUSTRALIA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 280 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 281 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 282 AUSTRALIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 283 AUSTRALIA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 284 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 285 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 286 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 287 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 288 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 289 REST OF ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 290 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 291 REST OF ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 292 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 293 REST OF ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 294 REST OF ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 295 REST OF ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 296 REST OF ASIA PACIFIC: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 297 REST OF ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 298 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 299 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 300 REST OF ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 301 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 302 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 303 LATIN AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 304 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 305 LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 306 LATIN AMERICA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 307 LATIN AMERICA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 308 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 309 LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 310 LATIN AMERICA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 311 LATIN AMERICA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 312 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 313 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 314 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 315 BRAZIL: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 316 BRAZIL: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 317 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 318 BRAZIL: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 319 BRAZIL: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 320 BRAZIL: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 321 BRAZIL: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 322 BRAZIL: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 323 BRAZIL: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 324 BRAZIL: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 325 BRAZIL: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 326 BRAZIL: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 327 BRAZIL: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 328 MEXICO: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 329 MEXICO: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 330 MEXICO: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 331 MEXICO: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 332 MEXICO: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 333 MEXICO: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 334 MEXICO: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 335 MEXICO: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 336 MEXICO: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 337 MEXICO: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 338 MEXICO: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 339 MEXICO: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 340 MEXICO: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 341 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 342 REST OF LATIN AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 343 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 344 REST OF LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 345 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 346 REST OF LATIN AMERICA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 347 REST OF LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 348 REST OF LATIN AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 349 REST OF LATIN AMERICA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 350 REST OF LATIN AMERICA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 351 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 352 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP,2022-2029 (USD MILLION)
  • TABLE 353 REST OF LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 354 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 355 MIDDLE EAST & AFRICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 356 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 357 MIDDLE EAST & AFRICA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 358 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 359 MIDDLE EAST & AFRICA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 360 MIDDLE EAST & AFRICA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 361 MIDDLE EAST & AFRICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 362 MIDDLE EAST & AFRICA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 363 MIDDLE EAST & AFRICA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 364 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 365 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 366 MIDDLE EAST & AFRICA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 367 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 368 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 369 GCC COUNTRIES: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 370 GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 371 GCC COUNTRIES: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 372 GCC COUNTRIES: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 373 GCC COUNTRIES: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 374 GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 375 GCC COUNTRIES: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 376 GCC COUNTRIES: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 377 GCC COUNTRIES: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 378 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 379 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 380 GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 381 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 382 SAUDI ARABIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 383 SAUDI ARABIA: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 384 SAUDI ARABIA: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 385 SAUDI ARABIA: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 386 SAUDI ARABIA: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 387 SAUDI ARABIA: ORAL APPLIANCES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 388 SAUDI ARABIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 389 SAUDI ARABIA: PSG DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 390 SAUDI ARABIA: OXIMETERS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 391 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 392 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022-2029 (USD MILLION)
  • TABLE 393 SAUDI ARABIA: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022-2029 (USD MILLION)
  • TABLE 394 UAE: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 395 UAE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 396 UAE: PAP DEVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 397 UAE: FACIAL INTERFACES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 398 UAE: MASKS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 399 UAE: ACCESSORIES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 400 UAE: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 401 UAE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 402 UAE: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 403 UAE: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 404 UAE: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 405 UAE: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 406 UAE: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 407 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 408 REST OF GCC COUNTRIES: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 409 REST OF GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 410 REST OF GCC COUNTRIES: FACIAL INTERFACES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 411 REST OF GCC COUNTRIES: MASKS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 412 REST OF GCC COUNTRIES: ACCESSORIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 413 REST OF GCC COUNTRIES: ORAL APPLIANCES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 414 REST OF GCC COUNTRIES: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 415 REST OF GCC COUNTRIES: PSG DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 416 REST OF GCC COUNTRIES: OXIMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 417 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 418 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)
  • TABLE 419 REST OF GCC COUNTRIES: SLEEP APNEA DEVICES MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 420 OVERVIEW OF STRATEGIES ADOPTED BY KEY SLEEP APNEA DEVICE MANUFACTURING COMPANIES
  • TABLE 421 SLEEP APNEA DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 422 SLEEP APNEA DEVICES MARKET: PRODUCT FOOTPRINT
  • TABLE 423 SLEEP APNEA DEVICES MARKET: REGION FOOTPRINT
  • TABLE 424 SLEEP APNEA DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 425 SLEEP APNEA DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 426 SLEEP APNEA DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021– JUNE 2024
  • TABLE 427 SLEEP APNEA DEVICES MARKET: DEALS, JANUARY 2021– JUNE 2024
  • TABLE 428 SLEEP APNEA DEVICES MARKET: EXPANSIONS, JANUARY 2021– JUNE 2024
  • TABLE 429 SLEEP APNEA DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 430 RESMED: COMPANY OVERVIEW
  • TABLE 431 RESMED: PRODUCTS OFFERED
  • TABLE 432 RESMED: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 433 RESMED: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 434 RESMED: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 435 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 436 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 437 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW
  • TABLE 438 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCTS OFFERED
  • TABLE 439 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 440 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
  • TABLE 441 INSPIRE MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
  • TABLE 442 SOMNOMED: COMPANY OVERVIEW
  • TABLE 443 SOMNOMED: PRODUCTS OFFERED
  • TABLE 444 OPENAIRWAY: COMPANY OVERVIEW
  • TABLE 445 OPENAIRWAY: PRODUCTS OFFERED
  • TABLE 446 COMPUMEDICS LIMITED: COMPANY OVERVIEW
  • TABLE 447 COMPUMEDICS LIMITED: PRODUCTS OFFERED
  • TABLE 448 COMPUMEDICS LIMITED: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 449 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG: COMPANY OVERVIEW
  • TABLE 450 LOWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG: PRODUCTS OFFERED
  • TABLE 451 DRIVE DEVILBISS HEALTHCARE: COMPANY OVERVIEW
  • TABLE 452 DRIVE DEVILBISS HEALTHCARE: PRODUCTS OFFERED
  • TABLE 453 BMC MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 454 BMC MEDICAL CO., LTD.: PRODUCTS OFFERED
  • TABLE 455 BRAEBON MEDICAL CORPORATION: COMPANY OVERVIEW
  • TABLE 456 BRAEBON MEDICAL CORPORATION: PRODUCTS OFFERED
  • TABLE 457 DYNAFLEX: COMPANY OVERVIEW
  • TABLE 458 DYNAFLEX.: PRODUCTS OFFERED
  • TABLE 459 DYNAFLEX: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 460 PANTHERA DENTAL: COMPANY OVERVIEW
  • TABLE 461 PANTHERA DENTAL: PRODUCTS OFFERED
  • TABLE 462 PANTHERA DENTAL: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 463 PANTHERA DENTAL: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
  • TABLE 464 MYERSON LLC: COMPANY OVERVIEW
  • TABLE 465 MYERSON LLC: PRODUCTS OFFERED
  • TABLE 466 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 467 PROSOMNUS SLEEP TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 468 PROSOMNUS SLEEP TECHNOLOGIES: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 469 NIDEK MEDICAL INDIA: COMPANY OVERVIEW
  • TABLE 470 TOMED GMBH: COMPANY OVERVIEW
  • TABLE 471 LIVANOVA PLC: COMPANY OVERVIEW
  • TABLE 472 LIVANOVA PLC: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 473 INVACARE CORPORATION: COMPANY OVERVIEW
  • TABLE 474 MPOWRX HEALTH & WELLNESS PRODUCTS INC.: COMPANY OVERVIEW
  • TABLE 475 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 476 SICAT GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 477 VIVOS THERAPEUTICS, INC.: COMPANY OVERVIEW
  • TABLE 478 VIVOS THERAPEUTICS, INC.: PRODUCT APPROVALS, JANUARY 2021–JUNE 2024
  • TABLE 479 VIVOS THERAPEUTICS, INC.: DEALS, JANUARY 2021–JUNE 2024
  • TABLE 480 VIVOS THERAPEUTICS, INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
  • TABLE 481 AIRWAY MANAGEMENT: COMPANY OVERVIEW
  • TABLE 482 AIRWAY MANAGEMENT: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
  • TABLE 483 APNEA SCIENCES: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 SLEEP APNEA DEVICES MARKET: SEGMENTS COVERED
  • FIGURE 2 SLEEP APNEA DEVICES MARKET: REGIONS COVERED
  • FIGURE 3 SLEEP APNEA DEVICES MARKET: YEARS CONSIDERED
  • FIGURE 4 SLEEP APNEA DEVICES MARKET: RESEARCH DESIGN
  • FIGURE 5 LIST OF KEY PRIMARIES (DEMAND AND SUPPLY SIDES)
  • FIGURE 6 SLEEP APNEA DEVICES MARKET: KEY INDUSTRY INSIGHTS
  • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 8 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 9 BOTTOM-UP APPROACH: PATIENT-BASED ANALYSIS
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 SLEEP APNEA DEVICES MARKET: TOP-DOWN APPROACH
  • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 SLEEP APNEA DEVICES MARKET: STUDY ASSUMPTIONS
  • FIGURE 14 SLEEP APNEA DEVICES MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 SLEEP APNEA DEVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 SLEEP APNEA DEVICES MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 SLEEP APNEA DEVICES MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 SLEEP APNEA DEVICES MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE MARKET
  • FIGURE 20 THERAPEUTIC DEVICES SEGMENT TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 21 US AND THERAPEUTIC DEVICES SEGMENT ACCOUNTED FOR LARGER MARKET SHARES IN 2023
  • FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 23 SLEEP APNEA DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • FIGURE 25 SUPPLY CHAIN ANALYSIS: DIRECT DISTRIBUTION TO BE PREFERRED STRATEGY OF PROMINENT COMPANIES
  • FIGURE 26 SLEEP APNEA DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SLEEP APNEA DEVICES
  • FIGURE 28 KEY BUYING CRITERIA FOR END USERS OF SLEEP APNEA DEVICES
  • FIGURE 29 SLEEP APNEA DEVICES MARKET: ECOSYSTEM MAP
  • FIGURE 30 TOP 10 COMPANIES WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2023
  • FIGURE 31 REVENUE SHIFT IN SLEEP APNEA DEVICES MARKET
  • FIGURE 32 INVESTMENT & FUNDING SCENARIO FOR KEY PLAYERS (2018-2023)
  • FIGURE 33 SLEEP APNEA DEVICES MARKET: PRESCRIPTION PATTERN ASSESSMENT
  • FIGURE 34 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA DEVICES MARKET, 2021-2023 (USD MILLION)
  • FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SLEEP APNEA DEVICES MARKET (2023)
  • FIGURE 38 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 39 SLEEP APNEA DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 40 SLEEP APNEA DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 SLEEP APNEA DEVICES MARKET: PRODUCT COMPARATIVE ANALYSISFOR CPAP DEVICES
  • FIGURE 44 RESMED: COMPANY SNAPSHOT (2023)
  • FIGURE 45 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)
  • FIGURE 46 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2024)
  • FIGURE 47 INSPIRE MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 48 SOMNOMED: COMPANY SNAPSHOT (2023)
  • FIGURE 49 COMPUMEDICS LIMITED: COMPANY SNAPSHOT (2023)
  • FIGURE 50 PROSOMNUS SLEEP TECHNOLOGIES: COMPANY SNAPSHOT (2023)